Skip to main content

LabCorp Launches Clinical Sequencing Business, Enlighten Health Genomics

NEW YORK (GenomeWeb) – Laboratory Corporation of America today launched Enlighten Health Genomics to leverage the capabilities of next-generation sequencing technology in the clinical setting.

Part of LabCorp's Enlighten Health business — which provides services and tools to improve treatment decisions, lower costs, and improve patient outcomes — Enlighten Health Genomics will combine LabCorp's infrastructure and capabilities with the expertise of geneticists to offer diagnostic services, NGS analysis and interpretation, and genetic counseling.

Later this year, Enlighten Health Genomics will launch a whole-exome sequencing testing service called ExomeReveal, which will perform genome-wide interpretation of children with serious childhood genetic diseases, as well as diagnostic interpretation for patients regardless of age.

"Enlighten Health Genomics is an important part of LabCorp's strategy to capitalize on our unique assets, create new sources of revenue from our core capabilities, and meaningfully differentiate us from competitors," LabCorp Chairman and CEO David King said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.